Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Patients With Plaque Psoriasis

NCT05739435 is registered in ClinicalTrials.gov with Alumis Inc as lead sponsor.

NCT NCT05739435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05739435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Patients With Plaque Psoriasis
Lead sponsor
Alumis Inc
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 17, 2023
Completion date
December 31, 2027
Enrollment
165 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

plaque psoriasis